Abbott Laboratories (ABT) Current Taxes (2009 - 2026)

Abbott Laboratories has disclosed Current Taxes across 18 years of filings, most recently posting $411.0 million for Q2 2026.

• In Q2 2026, Current Taxes rose 5.38% year-over-year to $411.0 million; the TTM figure through Jun 2026 stood at $411.0 million (up 5.38% YoY), while the FY2025 annual figure was $569.0 million, down 4.21% from the prior year.
• Current Taxes came in at $411.0 million for Q2 2026 at Abbott Laboratories, down from $598.0 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $713.0 million in Q3 2024 to a low of $273.0 million in Q2 2023.
• Average Current Taxes over 5 years is $457.7 million, with a median of $440.0 million recorded in 2025.
• Year-over-year, Current Taxes jumped 124.21% in 2024 and plunged 35.11% in 2025.
• Over 5 years, Current Taxes stood at $343.0 million in 2022, then surged by 43.44% to $492.0 million in 2023, then gained by 20.73% to $594.0 million in 2024, then fell by 4.21% to $569.0 million in 2025, then retreated by 27.77% to $411.0 million in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $411.0 million in Q2 2026, $598.0 million in Q1 2026, and $569.0 million in Q4 2025.